Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2026-01-05 @ 3:45 AM
Study NCT ID:
NCT00004856
Status:
TERMINATED
Last Update Posted:
2013-05-03
First Post:
2000-03-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Distal Urethral Cancer | View |
| None | Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | View |
| None | Proximal Urethral Cancer | View |
| None | Recurrent Bladder Cancer | View |
| None | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | View |
| None | Recurrent Urethral Cancer | View |
| None | Stage IV Bladder Cancer | View |
| None | Transitional Cell Carcinoma of the Bladder | View |
| None | Urethral Cancer Associated With Invasive Bladder Cancer | View |
Keywords: